Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use.
Smelson
David A
DA
Tunis
Sandra L
SL
Nyhuis
Allen W
AW
Faries
Douglas E
DE
Kinon
Bruce J
BJ
Ascher-Svanum
Haya
H
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D006801:Humans; D000077152:Olanzapine; D010352:Patient Dropouts; D018967:Risperidone / Q000627:therapeutic use; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy*; D019966:Substance-Related Disorders / Q000150:complications*; D013997:Time Factors; D016896:Treatment Outcome; D016312:Treatment Refusal
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D018967:Risperidone; D000077152:Olanzapine